Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological malignancies, and a potential ace-in-the-hole against antigen-negative relapse

Overview of attention for article published in Leukemia & Lymphoma, September 2017

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 76 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,003 followers.

Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological malignancies, and a potential ace-in-the-hole against antigen-negative relapse. https://t.co/yhfWp7BTjf https://t.co/7zS0DhHTxz

20 Dec 2018

Reply Repost Favourite

Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological… https://t.co/mdzrs38UtU #leukemia https://t.co/4Yq6s2yywy

14 Sep 2017

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.